IPL v. Sony: FederalCircuit Holds PTAB Did Not Violate Mandate Rule and Affirms Obviousness Determination July 20, 2026 In Intellectual Pixels Limited v. Sony Interactive Entertainment LLC, the Federal ...
FederalCircuit Affirms Patent Invalidity Where Inventorship Error Cannot Be Corrected Under 35 U.S.C. §256 September 28, 2026 On April 2, 2026, the U.S. Court of Appeals for the FederalCircuit affirmed ...
NHK-Fintiv Rule Challenges Look Futile at FederalCircuit April 6, 2021 The NHK-Fintiv rule allows the Patent Trial and Appeal Board (PTAB) to deny institution of an inter partes review petition based ...
FederalCircuit Affirms Patent Invalidity Where Inventorship Error Cannot Be Corrected Under 35 U.S.C. §256 Author: Nathan Zwartz September 28, 2026 On April 2, 2026, the U.S. Court of Appeals for ...
FederalCircuit Reverses District Court's Invalidity Ruling on Written Description in Novartis v. Torrent February 18, 2025 In a precedential opinion issued on January 10, 2025, the United States Court ...
Supreme Court Affirms FederalCircuit Decision in Amgen v. Sanofi May 18, 2023 In a unanimous opinion the Court decided that the FederalCircuit’s decision was correct. The Court noted that that ...
The FederalCircuit Takes Design Patent Obviousness En Banc July 11, 2023 The FederalCircuit on June 30 granted a petition for re-hearing en banc of its per curiam decision in LKQ Corp. v. GM Global ...
FederalCircuit Refuses to Construe "Configured For" as More Than "Capable Of" March 12, 2026 In In re Blue Buffalo Enterprises, Inc., No. 2024-1611 (Fed. Cir. Jan. 14, 2026), the FederalCircuit affirmed ...
FederalCircuit Upholds PTAB Finding of Obviousness in Pfizer vs. Sanofi March 18, 2024 In Pfizer Inc. vs. Sanofi Pasteur Inc., the FederalCircuit upheld the Patent Trial and Appeal Board (PTAB) decision ...
The FederalCircuit Rejects PacBio's Argument that Oxford Used the Then-Emerging Global COVID-19 Crisis to Win on Invalidity for Lack of Enablement July 15, 2021 In the recent decision PacificBiosciences ...